Press Release/Announcement

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

March 12, 2010

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; August 13, 2009.

This public health notification raises awareness of the potential for falsely elevated blood glucose readings in patients using therapeutic products containing certain non-glucose sugars.

Information

Related Resources From the Same Author(s)

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Relenza (zanamivir) inhalation powder.

March 12, 2010

Tamiflu (oseltamivir) for oral suspension: potential medication errors.

November 3, 2009

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico.

September 29, 2010

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death.

February 20, 2013

Wear face masks with no metal during MRI exams.

December 16, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Related Resources

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

March 4, 2015

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

January 19, 2011

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

Relenza (zanamivir) inhalation powder.

March 12, 2010

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

See More About The Topic

Health Care Providers

Quality and Safety Professionals

Endocrinology

Diagnostic Test Interpretation Error

Latent Errors

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site

Submit Your Training

Continue as a Guest

Continue Logged In

Submit Your Training

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your Toolkit

Continue as a Guest

Continue Logged In

Submit Your Toolkit

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your WebM&M Case

Continue as a Guest

Continue Logged In

Submit Your WebM&M Case

Continue as a Guest

Already have a PSNet

Account?

New Users